THE ROXTON PRACTICE — All Prescriptions & Medications — Page 15
Practice Code: B81039 | IMMINGHAM, DN40 1JW
Showing results 701-750 of 905
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Acrivastine | 26 | 1,876 | £547 | +111.1% ▲ |
| Meptazinol hydrochloride | 26 | 2,912 | £546 | -21.4% ▼ |
| Phenytoin | 26 | 36.5K | £296 | +136.9% ▲ |
| Ofloxacin | 26 | 650 | £723 | +216.4% ▲ |
| Levonorgestrel | 26 | 2,051 | £51 | +219.8% ▲ |
| 26 | 323 | £2.7K | +84.6% ▲ | |
| 26 | 443 | £616 | +195.8% ▲ | |
| 26 | 78 | £18 | -27.1% ▼ | |
| Linaclotide | 25 | 700 | £892 | +36.8% ▲ |
| Analgesics with anti-emetics | 25 | 660 | £239 | +76.7% ▲ |
| Doxycycline monohydrate | 25 | 580 | £324 | +130.2% ▲ |
| Vardenafil | 25 | 124 | £251 | +79.0% ▲ |
| Powder delisted probiotic (0913531) | 25 | 750 | £1.0K | +265.9% ▲ |
| Tube feed 0.8 kcal/ml with fibre, higher protein (0914011) | 25 | 499.0K | £8.0K | +104.1% ▲ |
| Mometasone furoate/olopatadine hydrochloride | 25 | 25 | £315 | +130.1% ▲ |
| Other barrier preparations | 25 | 1,470 | £156 | +322.5% ▲ |
| Tars | 25 | 4,175 | £279 | +198.3% ▲ |
| 25 | 56 | £2.4K | +175.5% ▲ | |
| 25 | 1,850 | £373 | +163.8% ▲ | |
| Levomepromazine hydrochloride | 24 | 250 | £466 | +4.2% ▲ |
| Eletriptan | 24 | 402 | £1.4K | +143.1% ▲ |
| Bromocriptine | 24 | 1,058 | £2.1K | +261.8% ▲ |
| Prednisolone sodium phosphate | 24 | 740 | £440 | +88.1% ▲ |
| 24 | 466 | £882 | -13.3% ▼ | |
| 24 | 120 | £372 | +192.4% ▲ | |
| 24 | 1,560 | £4.9K | +97.1% ▲ | |
| 24 | 1,080 | £2.6K | +57.6% ▲ | |
| Aspirin | 23 | 866 | £284 | +134.0% ▲ |
| Pivmecillinam hydrochloride | 23 | 340 | £176 | -56.2% ▼ |
| Drospirenone | 23 | 1,960 | £325 | +257.4% ▲ |
| Tube feed 1 kcal/ml (0914011) | 23 | 418.0K | £6.0K | +206.5% ▲ |
| Penicillamine | 23 | 644 | £1.4K | +144.5% ▲ |
| Glycopyrronium bromide | 23 | 240 | £428 | -3.5% ▼ |
| 23 | 156 | £173 | -29.9% ▼ | |
| Propantheline bromide | 22 | 2,738 | £2.2K | +69.5% ▲ |
| Sodium cromoglicate | 22 | 3,296 | £4.7K | +112.7% ▲ |
| Bempedoic acid/Ezetimibe | 22 | 600 | £1.1K | -64.0% ▼ |
| Atomoxetine hydrochloride | 22 | 910 | £1.9K | -34.9% ▼ |
| Exenatide | 22 | 52 | £1.7K | +25.5% ▲ |
| Phased formulations of ethinylestradiol | 22 | 1,470 | £72 | +393.0% ▲ |
| Diethylamine salicylate | 22 | 2,200 | £68 | -18.5% ▼ |
| 22 | 305 | £646 | +428.9% ▲ | |
| Acetylcysteine | 21 | 720 | £462 | -70.6% ▼ |
| Etonogestrel/ethinylestradiol | 21 | 49 | £483 | +298.0% ▲ |
| Vitamin A | 21 | 1,324 | £128 | +86.2% ▲ |
| Other health supplement preparations | 21 | 2,124 | £226 | -55.8% ▼ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913051) | 21 | 95.5K | £2.1K | +140.1% ▲ |
| Pilocarpine hydrochloride | 21 | 210 | £708 | +104.6% ▲ |
| 21 | 54 | £1.1K | +106.9% ▲ | |
| Liothyronine sodium | 20 | 1,423 | £3.5K | -6.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.